Report type: Weekly Strategy
”Positioning of major SQ days, eyeing next year’s market”
The “major SQ Day” (11/12), on which the SQ (Special Quotation) for the final settlement of stock index futures and options contracts overlaps, seems to be positioned as an important milestone pointing towards the upward movement of the Nikkei Average which had dipped to its low of 16,358 points on 19/3 this year.
First of all, after the market’s upturn from 19/3 came to a halt on 9/6 (high value of 23,185 points), it rebounded again after two dips to (1) a low of 21,529 points on 15/6 and (2) a low of 21,710 points on 31/7. While the number of business days from 19/3 to 31/7 is 90 days, the 90th business day counting from 31/7 (excluding the TSE system failure day of 1/10) falls on 11/12. The reason for focusing on 31/7, when the stock price was higher than on 15/6, as a turning point is that TOPIX, which is more reflective of the overall market price of the TSE 1st section, was lower on 31/7 (low of 1,496 points) than on 15/6 (low of 1,530 points).
Next, the average of the Nikkei Average of 26,894 points (7/12), which is the highest price of the year as of 11/12, and the year’s lowest of 16,358 points, viz 21,626 points, is almost the same level as the average of (1) and (2) above (21,619 points). If we position the Nikkei Average of around 21,600 points as the midpoint of this year’s market range, the upward movement since March this year may have reached the level deemed as the target for the upper limit of the market range. If the market were to continue to rise next year, it seems that a certain amount of time off will be needed as an adjustment phase. As the saying goes, “take a rest from the market” for more objective observation.
For reference, looking back at the Nikkei Average in the latter half of the 1980s, after reaching a high of 26,646 points in early October of that year, it fell to almost 21,000 points in November, 1987 due to Black Monday. The closing price at the end of that year was 21,564 points. The following year, 1988, it rose almost consistently from the beginning of the year, closing at 30,264 points at the end of that year.
In the foreign exchange market, the weakening of the US dollar (appreciation of the yen) against the backdrop of the Fed’s monetary easing, such as currencies of resource-rich countries and emerging countries appreciating against the US dollar, is seen as a sign of risk appetite for Japanese stocks, thereby creating the conditions for buying. The weighted average PBR (price-to-book-value ratio) of the Nikkei Average at the close of 10/12 this year was 1.19 times, and the weighted average BPS (net asset price per share) equivalent to 1.0 times was 22,484 points. If the BPS rises by about 5%to 23,600 points next year, and the PBR rises to 1.25 times, then the Nikkei Average will be 29,500 points. This does not seem to be an unrealistic assumption. If some positive aspects emerge, such as higher-than-expected recurring profit growth, then next year could be a repeat of 1988.
In the 14/12 issue, we will be covering Toray (3402), TerraSky (3915), Anritsu (6754), and eGuarantee (8771).
・Basic material manufacturer established in 1926. Conducts businesses related to fiber, functional chemical products, carbon fiber composite materials, environment / engineering, life sciences, etc. Top in the world for carbon fiber and polyester film for aircrafts.
・For 1H (Apr-Sep) results of FY2020/3 announced on 6/11, net sales decreased by 19.2% to 856.069 billion yen compared to the same period the previous year, core operating income decreased by 52.3% to 34.096 billion yen, and operating income decreased by 92.0% to 5.503 billion yen. Although the global economy began to recover from July, operating income was affected by the recording of impairment losses at a US subsidiary due to lower profitability caused by sluggish demand for aircrafts.
・For its full year plan, net sales is expected to decrease by 11.1% to 1.86 trillion yen compared to the previous year, and operating income excluding profits and losses caused by non-recurring factors to decrease by 36.3% to 80.0 billion yen. On 7/12, CME of the US futures exchange newly listed the “Nasdaq Veles California Water Index” futures. Amid concerns about global water shortages in the near future, the company will be exporting its desalination plant water treatment membranes to Saudi Arabia, Iraq, Indonesia, China and other countries.
・Established in 2006. Comprises the solutions business based on the cloud systems of Salesforce and AWS (Amazon Web Service), and the product business that provides cloud services in Japan and overseas as a SaaS vendor.
・For 1H (Mar-Aug) results of FY2021/2 announced on 15/10, net sales increased by 24.8% to 5.555 billion yen compared to the same period the previous year, and operating income increased by 52.9% to 528 million yen. In addition to the benefits of the expansion of cloud services, the number of contracts for “mitoco”, company’s groupware product, has increased for teleworking companies and local governments due to the spread of Covid-19.
・For its full year plan, net sales is expected to increase by 18.7% to 11.038 billion yen compared to the previous year, and operating income to decrease by 5.9% to 682 million yen. Company will benefit from the expected acquisition of business chat company, Slack Technologies (WORK), by solution-focused US-based salesforce.com (CRM). Furthermore, company has also signed a reseller agreement for home call center systems with Twilio (TWLO), a US communication solutions company.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
